Riastap 2600 mg/100mL
FIBRINOGEN HUMAN · INJECTION, SOLUTION · CSL Behring GmbH
No Recall History
Plain English
Riastap is a injection, solution containing fibrinogen human at 2600 mg/100mL, taken subcutaneous. Manufactured by CSL Behring GmbH.
Key Facts
- Brand Name
- Riastap
- Generic Name
- FIBRINOGEN HUMAN
- NDC Code (Product)
63833-892- Manufacturer
- CSL Behring GmbH
- Strength
- 2600 mg/100mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- BLA125317
- Marketing Start
- 01/16/2009
Recall History
No Recall HistoryFrequently Asked Questions
What is Riastap used for?
Riastap contains FIBRINOGEN HUMAN. It is a injection, solution taken subcutaneous. Consult your doctor for specific uses.
Is Riastap a controlled substance?
Riastap is not classified as a controlled substance by the DEA.
What is the generic name for Riastap?
The generic name for Riastap is FIBRINOGEN HUMAN. There are 11 other brand versions of FIBRINOGEN HUMAN.
What is the NDC code for Riastap 2600 mg/100mL?
The NDC (National Drug Code) for Riastap 2600 mg/100mL is 63833-892, listed by CSL Behring GmbH.
Other Fibrinogen Brands
See all →- TISSEEL Fibrin Sealant0338-4302
- ARTISS Fibrin Sealant86.5 mg/mL0338-9637
- TISSEEL Fibrin Sealant0338-4210
- TISSEEL Fibrin Sealant0338-4211
- EVARREST8.6 mg/cm263713-050
- TISSEEL Fibrin Sealant86.5 mg/mL0338-9560
- ARTISS Fibrin Sealant86.5 mg/mL0338-9639
- TISSEEL Fibrin Sealant86.5 mg/mL0338-9568
- ARTISS Fibrin Sealant86.5 mg/mL0338-9641
- TISSEEL Fibrin Sealant86.5 mg/mL0338-9564
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)